Usana Health Sciences's three largest insider shareholders as of April 22, 2026 are Myron W Wentz (TenPercentOwner, 7.41Mn shares), Kevin Guest (Ceo Exec. Chairman Of Board, 45.38K shares), Jim Brown (Ceo President, 16.93K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Myron W Wentz | - | 0 | 7,408,345 | 05 Sep, 2025 |
| Kevin Guest | Ceo Exec. Chairman Of Board | 45,381 | 0 | 03 Mar, 2026 |
| Jim Brown | Ceo President | 16,934 | 0 | 28 Jul, 2025 |
| Paul A. Jones | Chief People Officer | 12,374 | 0 | 03 Mar, 2026 |
| Timothy E Wood | E.V.P. Of R And D | 9,820 | 0 | 26 Jan, 2026 |
| Walter Noot | Chief Operating Officer | 9,256 | 0 | 03 Mar, 2026 |
| J Scott Nixon | - | 8,756 | 0 | 26 Jan, 2026 |
| David Mulham Mulham | Chief Sales Officer | 8,387 | 0 | 11 Dec, 2025 |
| Robert Auciaux | - | 8,092 | 0 | 11 May, 2022 |
| Brent Neidig | Chief Commercial Officer | 7,513 | 0 | 03 Mar, 2026 |
| Frederic J Winssinger | - | 7,044 | 0 | 26 Jan, 2026 |
| Xia Ding | - | 6,584 | 0 | 26 Jan, 2026 |
| John Turman Fleming | - | 5,623 | 0 | 26 Jan, 2026 |
| G Doug Iiekking | Chief Financial Officer | 5,360 | 0 | 02 Mar, 2026 |
| Peggie Pelosi | - | 4,975 | 0 | 26 Jan, 2026 |
| Joshua Foukas | Chief Legal Officer | 3,791 | 0 | 03 Mar, 2026 |
| Kathryn Michelle Armstrong | Chief Scientific Officer | 2,823 | 0 | 03 Mar, 2026 |
| Robert A Sinnott | Chief Scientific Officer | 318 | 0 | 26 Oct, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Mar, 2026 | Gilbert A Fuller | Common Stock | D | 1,058 | $17.00 | 0 | D | S |
| 03 Mar, 2026 | Peter Benedict | Common Stock | D | 4,553 | $19.38 | 0 | D | S |
| 27 Feb, 2026 | Paul A. Jones | Common Stock | A | 4,596 | - | 13,723 | D | M |
| 27 Feb, 2026 | Walter Noot | Common Stock | A | 7,422 | - | 12,400 | D | M |
| 27 Feb, 2026 | Kevin Guest | Common Stock | A | 7,856 | - | 48,709 | D | M |
| 27 Feb, 2026 | Peter Benedict | Common Stock | A | 3,906 | - | 5,727 | D | M |
| 27 Feb, 2026 | Joshua Foukas | Common Stock | A | 6,577 | - | 6,577 | D | M |
| 27 Feb, 2026 | Brent Neidig | Common Stock | A | 6,747 | - | 10,506 | D | M |
| 27 Feb, 2026 | Kathryn Michelle Armstrong | Common Stock | A | 4,190 | - | 4,838 | D | M |
| 27 Feb, 2026 | Peter Benedict | Common Stock | D | 1,174 | $21.52 | 4,553 | D | F |
| 27 Feb, 2026 | Walter Noot | Common Stock | D | 3,144 | $21.52 | 9,256 | D | F |
| 27 Feb, 2026 | Paul A. Jones | Common Stock | D | 1,349 | $21.52 | 12,374 | D | F |
| 27 Feb, 2026 | Kevin Guest | Common Stock | D | 3,328 | $21.52 | 45,381 | D | F |
| 27 Feb, 2026 | Kathryn Michelle Armstrong | Common Stock | D | 2,015 | $21.52 | 2,823 | D | F |
| 27 Feb, 2026 | Joshua Foukas | Common Stock | D | 2,786 | $21.52 | 3,791 | D | F |
| 27 Feb, 2026 | Brent Neidig | Common Stock | D | 2,993 | $21.52 | 7,513 | D | F |
| 27 Feb, 2026 | Brent Neidig | Restricted Stock Units | D | 6,747 | $0.00 | 67,447 | D | M |
| 27 Feb, 2026 | Kevin Guest | Restricted Stock Units | D | 7,856 | $0.00 | 127,206 | D | M |
| 27 Feb, 2026 | Joshua Foukas | Restricted Stock Units | D | 6,577 | $0.00 | 66,693 | D | M |
| 27 Feb, 2026 | Paul A. Jones | Restricted Stock Units | D | 4,596 | $0.00 | 46,611 | D | M |